Keratoconus is the most common corneal ectatic disorder. It is characterized by progressive
corneal thinning with resultant irregular astigmatism and myopia. Its prevalence has been …

Since the late 1990s corneal crosslinking (CXL) has been proposed as a new possibility to
stop progression of keratoconus or secondary corneal ectasia, with the promising aim to …

Purpose: To compare the relative 12-month corneal crosslinking (CXL) functional outcomes
using standard protocol and accelerated protocols in patients with progressive keratoconus …

Purpose: To systematically compare epithelial-off standard (SCXL) to accelerated corneal
collagen cross-linking (ACXL) for the treatment of keratoconus. Methods: PubMed, Embase …

Over the past 20 years, corneal crosslinking (CXL) has been used by surgeons to halt
progression in eyes with keratoconus. We reviewed the literature regarding the mechanism …

Corneal collagen crosslinking (CXL) is an approach used to increase the biomechanical
stability of the stromal tissue. Over the past 10 years, it has been used to halt the progression …

Purpose To evaluate the safety and efficacy of accelerated corneal crosslinking (CXL) in
patients with progressive keratoconus aged 18 years or less. Methods A total of 28 eyes …

Purpose To evaluate the efficacy of different accelerated corneal crosslinking (CXL)
treatment protocols in patients with progressive keratoconus. Setting Marmara University …

PURPOSE: To determine the relative impact of contact lens–assisted corneal cross-linking
(CACXL) and standard protocol CXL (CXL) on regional corneal stiffness using Brillouin …

Comparative study of long-term outcomes of accelerated and conventional collagen
crosslinking for progressive keratoconus | Eye Skip to main content Thank you for visiting …